Eosinophilic Duodenitis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2023-03-03
Clinical Trial Update: A Study to Assess Subcutaneous AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis [Phase 3]
A Phase 3 trial evaluating subcutaneous AK002 for eosinophilic gastritis and/or eosinophilic duodenitis has been withdrawn.